Joel Lexchin

Private Profits Versus Public Policy

The Pharmaceutical Industry and the Canadian State

• Gebundenes Buch

Produktbeschreibung

In his new work, Private Profits versus Public Policy, Joel Lexchin addresses this question as he examines how public policy with respect to the pharmaceutical industry has evolved in Canada over the past half century.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: University of Toronto Press
• Seitenzahl: 384
• Erscheinungstermin: 22. September 2016
• Englisch
• Abmessung: 229mm x 155mm x 28mm
• Gewicht: 680g
• ISBN-13: 9781442649170
• ISBN-10: 1442649178
• Artikelnr.: 45059798

Autorenporträt

Joel Lexchin is a Fellow of the Canadian Academy of Health Sciences. He is a professor in the School of Health Policy and Management at York University and works as an emergency physician at the University Health Network.

Inhaltsangabe

Abbreviations
Boxes, Tables and Figures
Introduction: Why do we care about the pharmaceutical industry in Canada?
Chapter 1: (De)regulation through cooperation
Chapter 2: Biased testing, hidden results and the regulation of clinical
trials
Chapter 3: Approving new drugs: better or just more?
Chapter 4: Regulating promotion or licensing deception?
Chapter 5: Health Canada and drug safety: how safe are we?
Chapter 6: Is intellectual property a right?
Chapter 7: How revenue is generated: prices, volume, mix and overall
spending
Chapter 8: Who gets the value from research and development?
Chapter 9: Canada, the pharmaceutical industry and access to medicines in
the Global South
Chapter 10: Courage my friends; ’tis not too late to build a better world
Acknowledgements